AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Netherlands

Kamerstuk 24 077, nr. 567

Motion on a pilot of MDMA-assisted therapy for people with severe PTSD [Motie van de leden Mutluer en Sneller over een pilot met MDMA-ondersteunde therapie voor mensen met ernstige PTSS]

Status

Pending

2025-2026

The motion asks the government to start an MDMA-therapy pilot under strict medical conditions; no vote result was confirmed in the official record.

IntroducedApr 21, 2026 (done)
PassedNext step (current)
Signed— (upcoming)
Law in effect— (upcoming)

Official text

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: zoek.officielebekendmakingen.nl

Legislative history

No dated actions recorded yet. The progress steps above show what is confirmed.

Loading bill…